About Janchor Partners
Janchor Partners is a private equity firm founded in 2009. It is primarily based in Hong Kong, China. As of Oct 2026, Janchor Partners is an active investor with a portfolio of 9 companies, comprising 9 funding rounds and 2 acquisitions. In the last 12 months, it has participated in 1 funding round. The firm primarily invests in companies based in China and Belgium. Its portfolio is spread across a wide range of sectors from Life Sciences to HealthTech. Its latest investment was a $***** Series E round in Sunrise on Aug 28, 2026 which also saw participation from Cpgroup, Jiuan and other investors.
Overall Janchor Partners portfolio has seen 4 IPOs, namely Remegen, Everest Medicines and Abbisko Therapeutics. A lot of funds co-invest with Janchor Partners, with names like Lake Bleu Capital sharing a substantial percentage of its portfolio.
Janchor Partners has a team of 18 people, including 2 partners.
Key Metrics
Janchor Partners' Portfolio
Janchor Partners has a portfolio of 9 companies. They have invested in a total of 9 companies. Their most recent investment was in Sunrise (Series E round) on Aug 28, 2026. Here are the most recent investments by Janchor Partners:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Aug 28, 2026 | Series E | 8309 | ||
Aug 10, 2021 | Series C | 4972 | ||
Jan 08, 2021 | Series D | 4026 | ||
Sep 27, 2020 | Series D | 1594 |
Janchor Partners has acquired 2 companies. Their most recent acquisition was of V5 Global on Jul 10, 2018. Here are the most recent acquisitions by Janchor Partners:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Jul 10, 2018 | Provider of recruitment and staffing services | $65.5K | 2005 | |
Jul 10, 2018 | Provider of recruitment services | - | 2004 |
Here is the portfolio snapshot of Janchor Partners:
Investments by Year
The maximum number of investments were made in 2018
Acquisitions by Year
The maximum number of acquisitions were made in 2018
Portfolio by Location
Companies are primarily in China and Belgium
Portfolio by Sector
Companies are primarily in Life Sciences
Team profile of Janchor Partners
Janchor Partners has a team of 18 members including 2 Partners and 3 Principals located in China, India and 2 more locations. Janchor Partners' team does not sit on the board of any company as of now.Here is a list of top team members in Janchor Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Hong Kong | - | - | |
Partner | Hong Kong | - | - | |
Principal | Hong Kong | - | - | |
Principal | Hong Kong | - | - | |
Principal | Hong Kong | - | - | |
Associate | Hong Kong | - | - | |
Associate | Mumbai | - | - | |
Associate | Mumbai | - | ||
Associate | Sydney | - | - | |
Associate | Hong Kong | - | - | |
Analyst | Hong Kong | - | - |
Co-investors of Janchor Partners
Over the past 17 years, 61 investors have co-invested in Janchor Partners's portfolio companies.
- Top Co-investors of Janchor Partners: 61 investors entered a company along with Janchor Partners. These include investors like Lake Bleu Capital (3 companies).
Janchor Partners News
•
Happy Forgings IPO Allotment: How To Check Application Status? Check HereIndia.com•Dec 22, 2023•Happy Forgings, Eastbridge Group, White Oak, Janchor Partners and 21 others
•
Samara, Goldman And Janchor-Backed HR Platform Makes Third AcquisitionVCCircle•Dec 06, 2023•FirstMeridian, Affluent, Janchor Partners, Goldman Sachs and 2 others
•
FPL Technologies racks up $75M in Series C round at $750MTechStory•Jan 12, 2022•OneScore, QED Investors, Sequoia Capital, Hummingbird Ventures and 4 others
•
OneCard raises $75 Mn at over $720 Mn valuationEntrackr•Dec 30, 2021•OneCard, QED Investors, Sequoia Capital, Matrix Partners India and 7 others
•
MediTrust Health Raises Over RMB2 Billion in Series C FinancingFinSMEs•Aug 17, 2021•MediTrust Health, Boyu Capital, Janchor Partners, LAV Asset Management and 10 others
•
Boyu, Janchor back China medical finance start-upAsian Venture Capital Journal•Aug 13, 2021•MediTrust Health, Boyu Capital, Janchor Partners, LAV Asset Management and 7 others
•
Investors entrust MediTrust with $308mGlobal Corporate Venturing•Aug 10, 2021•MediTrust Health, LAV Asset Management, Boyu Capital, Janchor Partners and 1 other
•
Abbisko absorbs $123m in series D roundGlobal Corporate Venturing•Jan 12, 2021•Sage Partners, Janchor Partners, Lake Bleu Capital, Orbimed and 6 others
•
Carlyle, Warburg Pincus co-lead $123m round in Shanghai biopharma firm AbbiskoDeal Street Asia•Jan 08, 2021•Abbisko Therapeutics, The Carlyle Group, Warburg Pincus, Orbimed and 9 others
•
Biopharmaceutical company "Yifang Bio" completes more than RMB 1 billion in Series D financing36Kr•Sep 28, 2020•PharmCube, Hillhouse Capital Group, Qiming Ventures, Janchor Partners
